November 2, 2026
SOHO Insider Hem/Onc Library Lymphoma Aggressive B-Cell Lymphomas

Aggressive B-Cell Lymphomas

Community Oncology News Community Oncology Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Video Interviews

Watch: Dr. Krish Patel on building partnerships between community and academic centers

Anthony_Letai_800x600
Cellular Therapy Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Meetings / Conferences AACR 2026 Multiple Myeloma Myelodysplastic Syndromes News

NCI director says institute is ‘stable’ after turbulent year

hospital bed
Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas

CAR-T improves survival, reduces hospital use in R/R LBCL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma SOHO 2026 Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026

European Commission
Lymphoma Aggressive B-Cell Lymphomas News

EC approves nivolumab and BV for relapsed or refractory cHL

Lymphoma Aggressive B-Cell Lymphomas

Real-world analysis finds similar efficacy for 2nd-line axi-cel, liso-cel in R/R LBCL

FDA
Lymphoma Aggressive B-Cell Lymphomas

FDA approves nivolumab in combination with AVD in cHL

Nirav shah
Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Meetings / Conferences Tandem Meetings 2026 News

Interim phase 2 analysis shows zamto-cel activity in DLBCL

Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas SOHO UK News SOHO Insider Podcast

Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas SOHO UK News

Q&A: Dr. Gohil on the multidisciplinary approach to HLH